Noscendo is led by a focused management team. A top- in-class advisory board for all relevant positions is currently being built up.

Fraunhofer IGB and Noscendo are closely cooperating in the area of clinical trials, wet-lab process and further technology development.

Partnerships to key players in the area of logistics and next generation sequencing services are currently being prepared.

Dr. Philip Stevens

CEO, Algorithmic Solutions, Costumer support, Back-End IP

Dr. Silke Grumaz

Trial coordination, Customer support, Clinical process surveillance, Front-end IP

Dr. Kai Sohn

Scientific networking, Clinical networking, New/emerging technologies, PoC - unlock new indications

Dr. Peter Haug

Business Development, Investment coordination, Licensing